The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Deciphering immune-genomic markers of hyperprogression in patients (Pts) with metastatic urothelial cancer (mUC) treated with immune checkpoint inhibitors (ICIs).
 
Nikhil Pramod
No Relationships to Disclose
 
Paul Pavicic
No Relationships to Disclose
 
Scott Dawsey
No Relationships to Disclose
 
Ubenthira Patgunarajah
No Relationships to Disclose
 
Kimberly Maroli
No Relationships to Disclose
 
Riya Malhotra
No Relationships to Disclose
 
Moshe Ornstein
Consulting or Advisory Role - AVEO; Bristol Myers Squibb Foundation; Eisai; Exelixis; Merck; Pfizer
Speakers' Bureau - Bristol-Myers Squibb; Merck
Research Funding - Aravive (Inst); Arcus Biosciences (Inst); Astellas Medivation (Inst); AstraZeneca/MedImmune (Inst); AVEO (Inst); Bristol-Myers Squibb (Inst); HiberCell (Inst); Merck (Inst); Pfizer (Inst); Surface Oncology (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Eisai; Exelixis; Merck; Pfizer
 
Timothy Gilligan
No Relationships to Disclose
 
Christopher Wee
Consulting or Advisory Role - Alphasights; Alphasights; Aptitude Health; Bayer HealthCare Pharmacuticals; Capvision; ClarityCo; Curio Science; DocDelta; Janssen; MJH Life Sciences; The Dedham Group
Research Funding - Merck
 
Omar Mian
Consulting or Advisory Role - Bayer; Blue Earth Diagnostics
Research Funding - Gilead Sciences (Inst); PathomIQ (Inst); Varian Medical Systems (Inst)
Travel, Accommodations, Expenses - Varian Medical Systems
(OPTIONAL) Uncompensated Relationships - Veracyte
 
Amanda Nizam
Honoraria - Aptitude Health; ASCO; Cleveland Clinic; Doximity; IntegrityCE; Mashup Media (GU Oncology Now); MECC Global Meetings; Targeted Oncology
Consulting or Advisory Role - Astellas Pharma; AVEO; EMD Serono/Merck; Mashup Media (GU Oncology Now); Medscape; Pfizer/Seagen
Travel, Accommodations, Expenses - ASCO; Mashup Media; MECC Global Meetings
 
Ying Ni
No Relationships to Disclose
 
Jane Nguyen
No Relationships to Disclose
 
C. Marcela Diaz-Montero
No Relationships to Disclose
 
Shilpa Gupta
Stock and Other Ownership Interests - BioNTech SE; Moderna Therapeutics; Nektar
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb/Medarex; EMD Serono; Foundation Medicine; Genzyme; Gilead Sciences; Merck; Natera; Pfizer; Seagen
Speakers' Bureau - Bristol-Myers Squibb; Gilead Sciences; Seagen
Research Funding - Bristol Myers Squibb Foundation (Inst); EMD Serono (Inst); Exelixis (Inst); Gilead Sciences (Inst); Merck (Inst); Moderna Therapeutics (Inst); Novartis (Inst); QED Therapeutics (Inst); Roche/Genentech (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate author royalty
Travel, Accommodations, Expenses - Pfizer